Relation Between Secretory Status of Growth Hormone, Serum Concentration of Insulin-like Growth Factor I, and Insulin-like Growth Factor Binding Protein 3 with Bone Mineral Density in Postmenopausal Women

Message:
Abstract:
Although the decline in sex steroid levels, particularly estradiol, may be largely responsible for age-related bone loss and osteoporotic fractures in older women, the insulin-like growth factor (IGF) system may also play a key role. This study aimed at evaluating the relation between the secretory status of growth hormones (GH), insulin-like growth factor I (IGF-I) and In-sulin-like growth factor binding protein 3 (IGFBP3) and bone mineral density (BMD) in postmenopausal women.
Materials and Methods
In a descriptive cross-sectional study, 150 postmenopausal healthy women were selected from among 1328 patients, referred to Tabriz Sina Hospital for bone densi-tometry, and divided into three groups according to their bone mineral density (BMD) (normal, os-teopenic and osteoporotic). The GH response to provocation by clonidine was assessed in all pa-tients.
Results
One hundred and fifty patients with a mean age of 65.6±6.6 years, were enrolled in this study. The impaired GH response to provocation by clonidine was significantly more common in the group with osteoporosis compared to their healthy and osteopenic counterparts (72% vs. 56% and 44%, respectively; p=0.018). Mean levels of serum IGF-I and IGFBP3 were not signifi-cantly different in healthy, osteopenic and os-teoporotic patients (55.4±20.7 μg/L, 57.5±21.7 μg/L, and 56.7±19.2 μg/L; p=0.880 and 2648.3±786.4 ng/ml, 2374.0±707.2 ng/ml, and 2613.5±1023.6 ng/ml; p=0.217, respectively). There was no strong cor-relation between the level of serum IGF-I or IGFBP3 and T-Score (r=-0.026, p=0.753 for IGF-1 and r=0.046, p=0.575 for IGFBP3).
Conclusion
The results of this study showed that the defective release of GH is more prevalent in postmenopausal women suffering from osteoporosis; such a defect was not observed regarding serums of IGF1 and IGFBP3. Prescription of supplementary doses of synthetic GH might be beneficial in this population.
Language:
English
Published:
International Journal of Endocrinology and Metabolism, Volume:6 Issue: 2, jun 2008
Page:
78
https://magiran.com/p581619  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!